Literature DB >> 3702342

Complement and neutrophil-mediated injury of perfused rat lungs.

M L Morganroth, G O Till, R G Kunkel, P A Ward.   

Abstract

It has previously been shown that systemic complement activation in rats leads to acute lung injury. We have now employed an ex vivo model of perfused rat lung which allows a more detailed examination of the role of circulating blood elements and pulmonary vascular pressure changes in the acute lung injury that occurs following cobra venom factor (CVF)-induced complement activation. In whole blood perfused lungs CVF infusion resulted in lung leukocyte sequestration, pulmonary vascular constriction, and acute lung injury. Lung injury was measured by quantitating the accumulation of [125I]-bovine serum albumin in lung parenchyma and alveolar lavage fluid. A histologic analysis of CVF-induced lung injury revealed the development of intravascular aggregates of platelets and accumulation of neutrophils, extensive bleb formation of pulmonary capillary interstitial endothelial cells, and interstitial and intraalveolar edema and intraalveolar hemorrhage. Experiments in lungs perfused with salt solution to which various blood elements were added showed that the development of lung injury was dependent on neutrophils and the interaction of CVF with heat-labile plasma components. The lung injury was not dependent on the presence of platelets or the pulmonary artery pressor response. Addition of catalase or erythrocytes to the lung perfusate significantly attenuated the acute lung injury. Like the development of lung injury, the pulmonary artery pressor response was dependent on the interaction of CVF with heat labile plasma components and neutrophils. The increase in PA pressure was not attenuated by the addition of catalase to the lung perfusate. These studies suggest that intravascular activation of the complement system leads to an acute microvascular injury which is dependent on neutrophils and the production of toxic oxygen metabolites. Pulmonary vascular constriction occurs independently of the associated lung injury and does not appear to be dependent on hydrogen peroxide production.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3702342

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  8 in total

Review 1.  Interactions between cancer cells and the microvasculature: a rate-regulator for metastasis.

Authors:  L Weiss; F W Orr; K V Honn
Journal:  Clin Exp Metastasis       Date:  1989 Mar-Apr       Impact factor: 5.150

2.  Isolation and characterization of circulating immune complexes from patients with pneumococcal pneumonia.

Authors:  M A Mellencamp; L C Preheim; T L McDonald
Journal:  Infect Immun       Date:  1987-08       Impact factor: 3.441

3.  Recurrent episodes of gram-negative bacteremia or endotoxemia change reactivity of pre- and post-capillary pulmonary segments to angiotensin or free radicals.

Authors:  O C Kirton; R G Gore; L M Reid; R C Jones
Journal:  Intensive Care Med       Date:  1992       Impact factor: 17.440

4.  Dissociation between the effects of zymosan on the systemic and pulmonary vessels of the rat.

Authors:  J Damas; D Lagneaux
Journal:  Br J Pharmacol       Date:  1991-10       Impact factor: 8.739

5.  Activation of C5 by cobra venom factor is required in neutrophil-mediated lung injury in the rat.

Authors:  G O Till; M L Morganroth; R Kunkel; P A Ward
Journal:  Am J Pathol       Date:  1987-10       Impact factor: 4.307

6.  The effects of oxygen radical--mediated pulmonary endothelial damage on cancer metastasis.

Authors:  F W Orr; I Y Adamson; D Warner; V Leroyer; L Werner; S Shaughnessy; L Young
Journal:  Mol Cell Biochem       Date:  1988-12       Impact factor: 3.396

7.  The effect of Pasteurella haemolytica and the leukotoxin of Pasteurella haemolytica on bovine lung explants.

Authors:  I W Wilkie; M H Fallding; P E Shewen; J A Yager
Journal:  Can J Vet Res       Date:  1990-01       Impact factor: 1.310

8.  The crystal structure of cobra venom factor, a cofactor for C3- and C5-convertase CVFBb.

Authors:  Vengadesan Krishnan; Karthe Ponnuraj; Yuanyuan Xu; Kevin Macon; John E Volanakis; Sthanam V L Narayana
Journal:  Structure       Date:  2009-04-15       Impact factor: 5.006

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.